You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 11, 2025

Details for Patent: 6,562,826


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,562,826
Title: Sustained release ranolazine formulations
Abstract:A sustained release ranolazine formulation contains an intimate mixture of ranolazine and a partially neutralized pH-dependent binder to form a film that is mostly insoluble in aqueous media below pH 4.5 and soluble in aqueous media above pH 4.5. The formulation is suitable for twice daily administration of ranolazine and is useful for controlling the rate of dissolution of ranolazine, and to maintain human plasma ranolazine levels at between 850 and 4000 ng base/mL.
Inventor(s): Wolff; Andrew A. (San Francisco, CA)
Assignee: CV Therapeutics, Inc. (Palo Alto, CA)
Application Number:10/254,707
Patent Claim Types:
see list of patent claims
Use; Dosage form; Delivery; Formulation; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a Patent: A Detailed Analysis of United States Patent 6,562,826

Introduction

Patents are a crucial component of intellectual property, providing exclusive rights to inventors and innovators for their creations. To fully appreciate the value and implications of a patent, it is essential to delve into its scope, claims, and the broader patent landscape. This article will provide a comprehensive analysis using the example of United States Patent 6,562,826, although the specific details of this patent are not provided here, we will use general principles and examples to illustrate the key points.

What is a Patent?

A patent is a form of intellectual property that grants the owner the right to exclude others from making, using, selling, and importing an invention for a certain period, typically 20 years from the filing date of the patent application[5].

Patent Scope and Claims

Definition of Patent Scope

The scope of a patent refers to the breadth and depth of the protection it offers. It is determined by the claims section of the patent, which outlines what the inventor considers to be the novel and non-obvious aspects of the invention[3].

Measuring Patent Scope

Researchers often use metrics such as independent claim length and independent claim count to measure patent scope. These metrics can indicate the complexity and breadth of the patent claims. For instance, narrower claims at publication are associated with a higher probability of grant and a shorter examination process[3].

Claims in a Patent

The claims section is the most critical part of a patent as it defines the legal boundaries of the invention. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[3].

Valuation of Patents

Methods of Valuation

The value of a patent can be determined using three primary methods: cost, income, and market.

  • Cost Approach: This method considers the cost of developing the patent, including research, development, and legal fees[1].
  • Income Approach: This method evaluates the future benefits provided by the patent, such as income or savings, and calculates their present value[1].
  • Market Approach: This involves determining the market value by looking at what a willing buyer would pay for a similar asset. This can include sales and asking price data for similar patents[1].

Patent Landscape and Litigation

Patent Infringement Litigation

Patent infringement litigation is a significant aspect of the patent landscape. Factors such as the volume and characteristics of recent patent litigation activity, views of stakeholders, and developments in the judicial system can influence patent litigation. For example, the rise of non-practicing entities (NPEs) that own patents but do not make products has been a point of contention, as they often assert patents for profit rather than to protect their own innovations[4].

Inter Partes Review (IPR)

The Patent Trial and Appeal Board (PTAB) conducts inter partes review (IPR) to challenge the validity of patent claims. This process can significantly impact the scope and claims of a patent, as seen in cases where claims are found to be anticipated by prior art patents[2].

Determining Inventorship

Importance of Correct Inventorship

Correctly determining who should be listed as an inventor is crucial. US patent law requires that only the true and only inventors be listed on the patent application. Errors in inventorship, especially those made with deceptive intent, can render the patent unenforceable[5].

Case Study: Patent Litigation and Scope

Example from Arbutus Biopharma Corporation v. Moderna Therapeutics

In the case of Arbutus Biopharma Corporation v. Moderna Therapeutics, the Patent Trial and Appeal Board found that all challenged claims of the '127 patent were invalid as anticipated by a prior art patent. This decision highlights the importance of ensuring that patent claims are novel and non-obvious, and how the scope of a patent can be significantly narrowed or invalidated through litigation[2].

The Role of the USPTO

Improving Patent Quality

The U.S. Patent and Trademark Office (USPTO) plays a critical role in ensuring the quality of issued patents. The USPTO has been recommended to examine trends in patent infringement litigation and link this information to internal data on the patent examination process to enhance patent quality[4].

Key Takeaways

  • Patent Scope: Defined by the claims section, it determines the breadth and depth of protection.
  • Claims: Independent and dependent claims define the legal boundaries of the invention.
  • Valuation: Cost, income, and market approaches are used to determine the value of a patent.
  • Litigation: Patent infringement litigation and IPR can significantly impact the scope and claims of a patent.
  • Inventorship: Correctly determining inventors is crucial to avoid rendering the patent unenforceable.
  • USPTO Role: The USPTO works to improve patent quality through examining trends in litigation and linking this to the examination process.

FAQs

What is the primary purpose of the claims section in a patent?

The primary purpose of the claims section is to define the legal boundaries of the invention, specifying what the inventor considers to be the novel and non-obvious aspects.

How is the scope of a patent measured?

The scope of a patent is often measured using metrics such as independent claim length and independent claim count, which can indicate the complexity and breadth of the patent claims.

What are the three main methods of valuing a patent?

The three main methods are the cost approach, income approach, and market approach. Each method evaluates the patent's value from different perspectives.

Why is correct inventorship important in patent applications?

Correct inventorship is crucial because errors, especially those made with deceptive intent, can render the patent unenforceable.

What is the role of the USPTO in patent litigation?

The USPTO examines trends in patent infringement litigation and links this information to internal data on the patent examination process to improve the quality of issued patents.

How does inter partes review (IPR) impact patent claims?

IPR can significantly impact patent claims by challenging their validity and potentially finding them anticipated by prior art, thus invalidating or narrowing the scope of the patent.

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. ARBUTUS BIOPHARMA CORPORATION v. MODERNATX, INC. - CAFC
  3. Patent Claims and Patent Scope - SSRN
  4. Assessing Factors That Affect Patent Infringement Litigation - GAO
  5. Determining Inventorship for US Patent Applications - Oregon State University

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,562,826

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 6,562,826

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
European Patent Office 1109558 ⤷  Try for Free PA2008017 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free CA 2008 00051 Denmark ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 91504 Luxembourg ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free PA2008017,C1109558 Lithuania ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free 09C0001 France ⤷  Try for Free
European Patent Office 1109558 ⤷  Try for Free SPC/GB08/058 United Kingdom ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 6 of 6 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.